Number of items: 6.
2006
Marshall, V. L., Patterson, J., Hadley, D. M., Grosset, K. A. and Grosset, D. G.
(2006)
Successful Antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP-CIT SPECT.
Movement Disorders, 21(12),
pp. 2247-2250.
(doi: 10.1002/mds.21159)
(PMID:17078059)
Marshall, V. L., Patterson, J., Hadley, D. M., Grosset, K. A. and Grosset, D. G.
(2006)
Two-year follow-up in 150 consecutive cases with normal dopamine transporter imaging.
Nuclear Medicine Communications, 27(12),
pp. 933-937.
(doi: 10.1097/01.mnm.0000243374.11260.5b)
2005
Marshall, V. and Grosset, D.
(2005)
Reply: the meaning of negative DAT and F‐Dopa PET scans in a patient with clinical Parkinson's disease.
Movement Disorders,
p. 118.
(doi: 10.1002/mds.20313)
2003
Marshall, V. and Grosset, D.
(2003)
Role of dopamine transporter imaging in routine clinical practice.
Movement Disorders, 18(12),
pp. 1415-1423.
(doi: 10.1002/mds.10592)
(PMID:14673877)
Marshall, V. and Grosset, D. G.
(2003)
Role of dopamine transporter imaging in the diagnosis of atypical tremor disorders.
Movement Disorders, 18(S7),
S22-S27.
(doi: 10.1002/mds.10574)
(PMID:14531042)
Marshall, V.L. and Grosset, D.G.
(2003)
Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes.
Neurology, 61(6),
p. 871.
(doi: 10.1212/WNL.61.6.871)
(PMID:14504352)
This list was generated on Fri Sep 29 16:58:32 2023 BST.